{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:46:20Z","timestamp":1790696780079,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jsat.2010.11.010","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T04:25:27Z","timestamp":1296102327000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients"],"prefix":"10.1016","volume":"40","author":[{"given":"Erin L.","family":"Winstanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolley E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.11.010_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199308000-00003","article-title":"Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine\/benzoylecgonine concentrations","volume":"13","author":"Batki","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.11.010_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0376-8716(96)01233-1","article-title":"A controlled trial of fluoxetine in crack cocaine dependence","volume":"41","author":"Batki","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.11.010_bb0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.11.010_bb0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.ALC.0000080165.72243.03","article-title":"Racially related health disparities and alcoholism treatment outcomes","volume":"27","author":"Brower","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2010.11.010_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0091-3057(90)90232-7","article-title":"Fluoxetine reduces intravenous cocaine self-administration in rates","volume":"35","author":"Carroll","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jsat.2010.11.010_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/00952999509002701","article-title":"Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers","volume":"21","author":"Covi","year":"1995","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jsat.2010.11.010_bb0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1360-0443.2002.00209.x","article-title":"Pharmacological treatment for cocaine dependence: a systematic review","volume":"97","author":"de Lima","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.11.010_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Durta","year":"2008","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.11.010_bb0030","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"2002"},{"key":"10.1016\/j.jsat.2010.11.010_bb0035","series-title":"Applied longitudinal data analysis","author":"Fitzmauice","year":"2004"},{"key":"10.1016\/j.jsat.2010.11.010_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004714-199506000-00004","article-title":"Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials","volume":"15","author":"Grabowski","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.11.010_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0376-8716(99)00082-4","article-title":"Patient histories, retention, and outcome models for younger and older adults in DATOS","volume":"57","author":"Grella","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.11.010_bb0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1176\/ajp.148.9.1218","article-title":"A behavioral approach to achieving initial cocaine abstinence","volume":"148","author":"Higgins","year":"1991","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.11.010_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004714-199010000-00007","article-title":"Apathy and indifference in patients on fluvoxamine and fluoxetine","volume":"10","author":"Hoehn-Saric","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.11.010_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsat.2005.12.007","article-title":"A 12-year follow-up of a treated cocaine-dependent sample","volume":"30","author":"Hser","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.11.010_bb0135","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/12429","article-title":"Cocaine addiction therapy\u2014are we partially there?","volume":"5","author":"Koob","year":"1999","journal-title":"Nature Med"},{"key":"10.1016\/j.jsat.2010.11.010_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1521-0391.1992.tb00361.x","article-title":"An open trial of sertraline for cocaine abuse","volume":"1","author":"Kosten","year":"1992","journal-title":"Am J Addict"},{"key":"10.1016\/j.jsat.2010.11.010_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation for substance abuse patients: The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2010.11.010_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: A double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2010.11.010_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0740-5472(95)02015-2","article-title":"Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users","volume":"12","author":"Oliveto","year":"1995","journal-title":"J Subst Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.11.010_bb0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jsat.2010.11.010_bb0075","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: A meta-analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.11.010_bb0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1360-0443.1997.tb02938.x","article-title":"Assessment of cocaine use with quantitative urinalysis and estimation of new uses","volume":"27","author":"Preston","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.11.010_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1037\/1064-1297.6.2.162","article-title":"Medication take-home doses and contingency management","volume":"6","author":"Schmitz","year":"1998","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.11.010_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2007.09.007","article-title":"The SRPHK1 outcomes measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day","volume":"93","author":"Somoza","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.11.010_bb0095","series-title":"State-Trait Inventory for Adults","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.jsat.2010.11.010_bb0100","series-title":"Optimal design for longitudinal and multilevel research: Documentation for the \u201cOptimal Design\u201d Software","author":"Spybrook","year":"2008"},{"key":"10.1016\/j.jsat.2010.11.010_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10550881003684582","article-title":"Women and addiction: The importance of gender issues in substance abuse research","volume":"29","author":"Tuchman","year":"2010","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2010.11.010_bb0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","article-title":"Medication development for addictive disorders: The state of the science","volume":"162","author":"Vocci","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jsat.2010.11.010_bb0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00004714-199412000-00005","article-title":"Fluoxetine alters the effects of intravenous cocaine in humans","volume":"14","author":"Walsh","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.11.010_bb0115","series-title":"College on the Problems of Drug Dependence","article-title":"Lack of efficacy of fluoxetine in depressed cocaine dependent subjects","author":"Winstanley","year":"2008"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:04Z","timestamp":1760038504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0740547210002497"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.11.010","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}